Top compounds associated with response to ZNF227


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 8e-08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.17 4e-07
mRNA ML311 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 6e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.15 6e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-07
Download CSV